Press Releases

• Cartography Biosciences: Advances Strategic Oncology Collaboration With Gilead’s First Option Target Exercise More
• GCAR and Purdue Pharma L.P.: Initiation of Tinostamustine in GBM AGILE Trial More
• Jaguar Health: Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs More
• Oxford BioTherapeutics: Enters Strategic Collaboration With Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours More
• Pulse Biosciences: Strengthens Executive Leadership Team More
• Rani Therapeutics: Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy More
• Seer and Precision Health Research, Singapore: Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples More
• Supira Medical: FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors More
• 23andMe Research Institute: New Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects More More

Financial News

• How Merck Slashed Its Bid for Terns Pharmaceuticals by $1B After Reviewing Cancer Drug Trial Data More*
• Kymera Therapeutics: Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate More More
• More on Gilead Taking Another Big Swing at Expanding Beyond HIV More* More More
• Outset Medical: Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) More

Media/Misc Coverage

• Mini Models of the Human Brain Are Revealing How This Complex Organ Takes Shape More
• More on Hologic Hiring Former Baxter Leader José Almeida as CEO More
• Pfizer Walks Away From ‘Underutilized’ Office Space in South San Francisco, Transitions Employees to Remote Roles More
  
• Subscribe to LifeSci Startup for Updates on US Startups More

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• Empowering Students Through STEM: A Conversation With Massachusetts Science & Engineering Fair Executive Director Helen Rosenfeld More
  
• From Seed to Series C: What Investors Look for Beyond the Science More
• Hiring Outlook: February Brings First YOY Job Increase Since 2022 More
• ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• Lilly’s Chief Technology Officer Retires After 35 Years; Astellas Strategy Exec Resigns More*
• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
• More Than Executive Search: Building Leadership for Every Stage of Growth More
• The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More

• Life Science Cares Boston 10th Annual Impact Breakfast April 13
  
• CMO Summit 360° April 13-14
• Drug Discovery Chemistry April 13-16
• IMMUNOLOGY2026 April 15-19
• Venture Cafe Cambridge Thursday Gathering April 16
• Advancing Rare Together - A Night at the Museum with Rare New England April 18
• Capital Connect: From Seed to Series A in Today’s Market April 23
  
• Southern California Life Sciences & Biotech Summit April 28
• Life Sciences PA Tailgate250 April 30
• Delaware’s DNA | 2026 Life Science Conference April 30
• SynBioBeta 2026 May 4-7
• 2026 Battle of the Bio\Tech Bands West  May 7
  
• AAPS National Biotechnology Conference May 11-14
• Bio-IT World Conference & Expo May 19-21

Companies

SF Bay Sponsors